Team
Douglas S. Hamilton (Co-Founder), Chief Executive Officer
Doug is Chief Executive Officer of i3 Pharmaceuticals, LLC. Previously, in 2004, he Co-Founded and held the position of President at Synerx Pharma, LLC, a specialty generic pharmaceutical company which was sold to Mylan Laboratories in 2011. Over his 30+ year career, he has held senior executive positions in Sourcing, New Product Development/Commercialization, Manufacturing and Business Development at leading pharmaceutical companies including Lederle Labs (now Pfizer), Bristol Myers Squibb, Novartis/Sandoz and Sanofi – Aventis. Mr. Hamilton holds a B.S. degree in Chemical Engineering from the New Jersey Institute of Technology as well as an MBA from Fairleigh Dickinson University.
Ram K. Kallur (Co-Founder), Vice President, Operations & Sourcing
Ram is Vice President of Operations and Sourcing at i3 Pharmaceuticals, LLC. Prior to that, he was a member and the Senior Vice President of Operations at Sigmapharm Laboratories, LLC. Ram worked at Pfizer as a Scientist, Process Development and worked for URL Pharma, Inc. (formerly URL/Mutual) as a formulation scientist and at Core Pharma as a Scientist, Analytical Research and Development. He has more than 16 years of diversified experience in pharmaceutical industry, where he gained experience in product and process development, analytical testing, quality assurance, process validation, commercial manufacturing, new product launch and engineering aspects of facility. Ram, as a team member and individually developed submitted, validated and launched several unique generic and paragraph IV drug products using his scientific, technical and quality oriented expertise. Mr. Kallur holds a M.S. degree in Industrial Pharmacy from the Arnold and Marie Schwartz College of Pharmacy of Long Island University and a B.S. degree in Pharmacy from Mangalore University, India.
Sunil V. Sagi (Co-Founder), Vice President, Scientific & Regulatory Affairs
Sunil is Vice President of Scientific and Regulatory Affairs of i3 Pharmaceuticals, LLC. Prior to that, he was a member and the Senior Vice President of Technology Development at Sigmapharm Laboratories, LLC and worked for URL Pharma, Inc. (formerly URL/Mutual) as the Manager of Technology Development, R&D. He has 16 years of experience in Research and Development and Regulatory Affairs and has successfully developed, submitted, validated and launched several unique generic and paragraph IV drug products. Mr. Sagi holds a M.S. degree in Industrial Pharmacy from the Arnold and Marie Schwartz College of Pharmacy of Long Island University and a B.S. degree in Pharmacy from Mangalore University, India.
Ishari P. Shrestha (Co-Founder), Vice President, Research & Development
Ishari is Vice President of Research and Development of i3 Pharmaceuticals, LLC. Prior to that, she was a member and the Senior Vice President of Product Development at Sigmapharm Laboratories, LLC. She worked for Kali Laboratories (Presently Par Pharmaceuticals) and URL Pharma, Inc. (formerly URL/Mutual) as the Manager of Product Development, R&D. She has 16+ years of experience in Research and Development and has successfully developed, submitted, validated and launched several unique generic and paragraph IV drug products. Ms. Shrestha holds a M.S. degree in Industrial Pharmacy from the Arnold and Marie Schwartz College of Pharmacy of Long Island University and a B.S. degree in Pharmacy from University of Sind, Pakistan.
Pete Valko, Chief Commercial Officer
Pete is Chief Commercial Officer of i3 Pharmaceuticals, LLC. Pete has a twenty year history in start-ups and high-growth generic companies. After over a decade at Merck & Co. in engineering, production and marketing roles, he joined Impax Laboratories and grew to Vice President, Generic Sales and Marketing. In 2009, he joined Mission Pharmacal Company to start-up and launch their generic subsidiary, BioComp Pharma. Mr. Valko holds a B.S. degree in Mechanical Engineering from Drexel University.
Dr. Saroja Ganti, Vice President, Quality Assurance & Compliance
Saroja is the Vice President of Quality Assurance & Compliance at i3 Pharmaceuticals, LLC. Prior to that, she worked as Senior Director & Head of Quality Systems at Pharmaceutics International Inc (“Pii”). She worked for Sigmapharm Laboratories as the Director of Analytical Chemistry, for Sun Pharma as Director of Quality Control and for URL Pharma, Inc. (formerly URL/Mutual) as Associate Director of Chemistry and Manufacturing Services. Saroja has over 30+ years’ experience in the pharmaceutical industry, with expertise in various technical roles of Quality Assurance, Quality Control and Analytical R&D, in Generics, Brand and Contract Manufacturing Development Companies. Dr. Ganti holds a Ph.D. in Organic Chemistry and an MBA in International Business.